Cécile Vicier
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- PARP inhibition in cancer therapy
- Cancer Cells and Metastasis
- CAR-T cell therapy research
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 36
- Cancer Immunotherapy and Biomarkers 17
- PARP inhibition in cancer therapy 6
- CAR-T cell therapy research 5
-
- Renal cell carcinoma treatment 8
- Prostate Cancer Treatment and Research 7
- Advanced Breast Cancer Therapies 6
- Co-authors
- Fabrice André (17 shared papers)Mónica Arnedos (5 shared papers)Stefan Michiels (6 shared papers)Céline Lefèbvre (3 shared papers)Hervé Bonnefoi (4 shared papers)Sherene Loi (1 shared paper)Carole Hélissey (1 shared paper)Stéphane Champiat (4 shared papers)
- Journals
- Journal of Clinical Oncology (15 papers)Annals of Oncology (5 papers)ESMO Open (2 papers)Frontiers in Immunology (2 papers)European Journal of Cancer (2 papers)
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
Cécile Vicier
51 papers receiving 790 citations
Peers
Comparison fields: 5 of 74
- Oncology 465
- Cancer Research 223
- Pulmonary and Respiratory Medicine 229
- Immunology 122
- Molecular Biology 338
Countries citing papers authored by Cécile Vicier
This map shows the geographic impact of Cécile Vicier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cécile Vicier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cécile Vicier more than expected).
Fields of papers citing papers by Cécile Vicier
This network shows the impact of papers produced by Cécile Vicier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cécile Vicier. The network helps show where Cécile Vicier may publish in the future.
Co-authors
The 25 scholars most cited alongside Cécile Vicier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 231 | |
| 2 | 2016 | 74 | |
| 3 | 2014 | 48 | |
| 4 | 2014 | 46 | |
| 5 | 2017 | 45 | |
| 6 | 2016 | 32 | |
| 7 | 2020 | 28 | |
| 8 | 2021 | 27 | |
| 9 | 2021 | 24 | |
| 10 | 2019 | 23 | |
| 11 | 2023 | 17 | |
| 12 | 2019 | 16 | |
| 13 | 2020 | 16 | |
| 14 | 2023 | 13 | |
| 15 | 2022 | 12 | |
| 16 | 2017 | 12 | |
| 17 | 2024 | 11 | |
| 18 | 2013 | 11 | |
| 19 | 2021 | 10 | |
| 20 | 2013 | 10 |
About Cécile Vicier
Cécile Vicier is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Genetics, having authored 53 papers that have together received 808 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (17 papers), Cancer Genomics and Diagnostics (10 papers), Renal cell carcinoma treatment (8 papers), Prostate Cancer Treatment and Research (7 papers), PARP inhibition in cancer therapy (6 papers), Advanced Breast Cancer Therapies (6 papers), CAR-T cell therapy research (5 papers) and BRCA gene mutations in cancer (5 papers). The work is most often cited by research in Oncology (465 citations), Cancer Research (223 citations), Pulmonary and Respiratory Medicine (229 citations), Immunology (122 citations) and Molecular Biology (338 citations). Cécile Vicier has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Fabrice André, Mónica Arnedos, Stefan Michiels, Céline Lefèbvre, Hervé Bonnefoi, Sherene Loi, Carole Hélissey, Stéphane Champiat, Suzette Delaloge and Maria Vittoria Dieci. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, ESMO Open, Frontiers in Immunology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.